CDEK
← All organizations

Vtesse Inc.

For profitWebsite ↗

Also known as: Vtesse, Inc., a Mallinckrodt Pharmaceuticals Company

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2014

Last known activity

Aug 19, 2019

Acquired by Sucampo → Mallinckrodt (2013) on Apr 3, 2017

Timeline

2010s

  1. Jun 1, 2014

    Vtesse Inc.— Founded

  2. Apr 3, 2017

    Sucampo— Acquired By

  3. Dec 26, 2017

    Mallinckrodt (2013)— Now

Drugs by trial phase (1 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (5)

Details

Founded
Gaithersburg, MD, US Jun 1, 2014
Last known activity
Aug 19, 2019